Filing Details
- Accession Number:
- 0001840315-23-000007
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-07 21:21:38
- Reporting Period:
- 2023-12-05
- Accepted Time:
- 2023-12-07 21:21:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1314102 | Eyepoint Pharmaceuticals Inc. | EYEP | Laboratory Analytical Instruments (3826) | 262774444 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1840315 | Therapeutics Ocumension | 56F, One Museum Place 669 Xin Zha Road Jing'An District, Shanghai F4 200041 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-12-05 | 733,758 | $19.91 | 2,276,963 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-12-06 | 266,242 | $18.41 | 2,010,721 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |